TET Gene Loss Triggered Recurrent Chromosomal Trisomy
Researchers found that TET deficiency drives aggressive lymphoid expansion and specific chromosomal gains.
Updated on Oct. 1, 2026 in Life Sciences
A study published on October 1, 2026, revealed that the loss of TET genes causes recurring chromosome 17 trisomy in iNKT cells. This process highlights how disrupted DNA methylation pathways facilitate the selection of aneuploid subclones.
Why it matters
Understanding how TET loss reshapes genome evolution explains the mechanisms behind aggressive tumor development. This research demonstrates how epigenetic deficiencies act as critical drivers of karyotypic evolution.
Single-cell whole-genome sequencing of iNKT cells during antigen and IL-2 stimulation tracked the expansion of aneuploid cells. Researchers also identified chromosome 6 trisomy in Tet-deficient mouse embryonic stem cells.
The details
TET-deficient iNKT cells transplanted into immunocompetent mice showed progressive enrichment of chromosome 17 trisomy during expansion. The findings indicate that both TET and DNMT3A deficiencies function as significant drivers of chromosomal instability.
Timeline
October 1, 2026: The research findings were published.
The Big Picture
This discovery fundamentally shifts our understanding of karyotypic evolution by linking epigenetic gene regulation to the selection of aneuploidy. It bridges gaps between DNA methylation pathways and the aggressive expansion observed in lymphoid tumors.
This research provides a template for identifying how genetic drivers contribute to cancer progression in clinical settings. By mapping these specific chromosomal anomalies, scientists can better target the epigenetic pathways that enable tumor growth.
The takeaway
Epigenetic maintenance is essential for preventing the selection of chromosomal abnormalities during rapid cell growth. Future research into DNA demethylation pathways may yield new insights into suppressing aggressive cellular expansion.
Further reading
For more information on current developments in genetics, visit the Life Sciences section.
Source note: This article includes information reported by Biorxiv.
